CIK 0001069899 · Large accelerated filer
PHIBRO ANIMAL HEALTH CORP
Sign in to watch- Ticker
- PAHC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 131840497
- Phone
- 201-329-7300
- Business address
- GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NJ, 07666
- Former names
- PHILIPP BROTHERS CHEMICALS INC
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale President and CEO sold 18,608 shares at an average $54.61 ($1,016,228)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 4 Planned sale President and CEO sold 21,120 shares at an average $53.86 ($1,137,593)
- 8-K Event Material agreement · New debt or obligation
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Planned sale President and CEO sold 21,120 shares at an average $54.79 ($1,157,091)
- 4 Planned sale President and CEO sold 21,120 shares at an average $56.89 ($1,201,595)
- 8-K Event Executive or director change
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Planned sale President and CEO sold 14,080 shares at an average $53.75 ($756,834)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale President and CEO sold 21,120 shares at an average $55.21 ($1,166,105)
- 4 Planned sale President and CEO sold 22,880 shares at an average $52.40 ($1,198,818)
- 4 Planned sale President and CEO sold 5,280 shares at $48.91 ($258,245)
- 144 Insider Sale of Securities
Page 3 of 39 · 774 filings